• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Up 0.13%

    Athersys, Inc. (ATHX)

    -NasdaqCM
    1.92 Down 0.04(2.04%) Aug 26, 4:00PM EDT
    Prev Close:1.96
    Open:1.94
    Bid:1.79 x 1000
    Ask:2.10 x 100
    1y Target Est:7.00
    Beta:-0.892196
    Next Earnings Date: 3-Nov-16ATHX Earnings announcement
    Day's Range:1.91 - 2.00
    52wk Range:0.94 - 2.90
    Volume:200,422
    Avg Vol (3m):516,622
    Market Cap:163.17M
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ATHXDown 2.04%163.17M
    OSIRDown 1.19%171.92M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.22
    Quarterly EPS Est (Sep-16) :-0.10
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.32

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback